Exploration of immune-modulatory effects of amivantamab in combination with pembrolizumab in lung and head and neck squamous cell carcinoma.
Lim SM, Kang SS, Kim DK, Lee SH, Synn CB, Baek S, Yang SM, Han YJ, Kim MH, Han H, Na K, Kim Y, Yun MR, Kim JH, Byeon Y, Kim YS, Lee JB, Hong MH, Curtin JC, Patel B, Bergiers I, Pyo KH, Cho BC.
Lim SM, et al. Among authors: han yj.
Cancer Res Commun. 2024 Jun 25. doi: 10.1158/2767-9764.CRC-24-0107. Online ahead of print.
Cancer Res Commun. 2024.
PMID: 38916448